Big Pharma Targets the 340B Safety Net, CMS Proposes We Stop Making Patients Wait 72 Hours for Drugs, and Employers Pay $1M Annually to Manage Digital Vendor Sprawl

Big Pharma Targets the 340B Safety Net, CMS Proposes We Stop Making Patients Wait 72 Hours for Drugs, and Employers Pay $1M Annually to Manage Digital Vendor Sprawl

Hey all, 

Happy Tuesday! It appears that "winning" in healthcare today has almost nothing to do with clinical outcomes and everything to do with mastering the expensive, performative art of navigating administrative minutiae. Whether it’s employers lighting millions on fire to manage a "sprawl" of cost-saving vendors or AbbVie litigating the literal definition of a "patient," the industry has successfully pivoted from providing care to perfecting the bureaucracy that obstructs it. We have reached a peak where the actual patient is essentially a secondary character in a high-stakes drama about prior authorization response times and regulatory arbitrage.

Enjoy the rundown! 

Jacob Brody (Co-Founder & CEO, ZorroRX)

[Substack] AbbVie Just Filed the Most Important 340B Lawsuit Nobody Saw Coming

AbbVie’s lawsuit against HRSA targets the loosely defined "patient" status that has allowed the 340B program to swell into an $81 billion behemoth, challenging the regulatory loopholes that facilitate massive drug-pricing arbitrage. By proposing a strict four-part eligibility test, the suit threatens to pull the plug on a system where drug manufacturer discounts have essentially become the duct tape holding the American healthcare safety net together. It is a bold move to dismantle a house of cards that is now "too big to fail," effectively daring the courts to find out what happens when you stop using pharmaceutical discounts to subsidize an entire nation’s crumbling healthcare infrastructure.

Full Article

[Modern Healthcare] CMS Proposals to Streamline Prior Authorizations

The Centers for Medicare and Medicaid Services has proposed a new regulation that would mandate significantly faster response times for prescription drug prior authorizations, requiring some insurers to resolve non-urgent requests within 24 hours. Additionally, the rule would force insurers across Medicaid, Medicare, and ACA exchanges to publicly disclose their denial rates and provide specific justifications for rejected medication requests to improve transparency. This federal push for efficiency aims to reduce administrative delays in patient care, a shocking departure from the traditional healthcare philosophy of making patients wait long enough to see if their symptoms—or their will to live—simply disappear first.

Full Article

[Fierce Healthcare] Digital Health Vendor Sprawl Costs

A Solera Health survey reveals that managing an average of eight or more digital health vendors has created a significant financial drain, with 90% of employers now spending over $1 million annually on vendor-related costs. These administrative burdens have intensified for 60% of organizations over the last three years, often resulting in median management expenses of $580,000 that can effectively negate the savings these digital solutions were intended to provide. It is a truly remarkable feat of modern administration that the healthcare industry has found a way to reliably extract every last cent of potential savings from the very tools designed to save money.

Full Article